Onc Xerna Therapeutics, Ltd. reported raising $30 Million in an initial SEC Form D filing, from an offering of $100 Million
Amount Raised
$30 Million
Round Type
Venture
WalthamBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as OncXerna Therapeutics, Ltd. that raised within 45 days of this round, from Fundz verified event records.
- Trevi Therapeutics raised $55M on April 18, 2022.
- Ambergen, Inc. raised $5M on April 15, 2022.
- Alume Biosciences raised $3M on April 15, 2022.
- Akston raised $5.2M on April 15, 2022.
- Sonomotion Inc. raised $12M on April 15, 2022.
- UbiVac raised $250K on April 15, 2022.
Who to call at OncXerna Therapeutics, Ltd., and when
A new round usually means OncXerna Therapeutics, Ltd. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OncXerna Therapeutics, Ltd. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncXerna Therapeutics, Ltd., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncXerna Therapeutics, Ltd.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OncXerna Therapeutics, Ltd. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
OncXerna Therapeutics, Ltd. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.